Development of a novel polyethylene glycol-corticosteroid-conjugate with an acid-cleavable linker

Journal of Drug Targeting

Volumn 19, Issue 6, 2011, Pages 434-445

  Funk, Dorothee ^a   Schrenk, Hans Hermann ^a   Frei, Eva ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

dexamethasone; drug targeting; inflammatory disease; lysosome; Polyethylene glycol

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE HYDRAZINO ACETIC ACID; MACROGOL; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONJUGATE; DRUG ACTIVITY; DRUG EFFICACY; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; FLUORINE NUCLEAR MAGNETIC RESONANCE; LYMPHOMA CELL LINE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXAMETHASONE; DRUG CARRIERS; DRUG DESIGN; GLYCINE; HUMANS; HYDRAZONES; HYDROGEN-ION CONCENTRATION; MASS SPECTROMETRY; MICE; MICROSCOPY, CONFOCAL; MOLECULAR STRUCTURE; POLYETHYLENE GLYCOLS; RECEPTORS, GLUCOCORTICOID;

EID: 79958800901     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.504271     Document Type: Article

References (46)

1. Becker M. (2008). Identification of a Cathepsin B-mediated cell death pathway in thymocytes with impact on negative selection. PhDThesis. University Heidelberg. http://www.ub.uni-heidelberg.de/ archiv/8615.
2. Bernstein A, Hurwitz E, Maron R, Arnon R, Sela M, Wilchek M. (1978). Higher antitumor efficacy of daunomycin when linked to dextran: in vivo and in vitro studies. J Natl Cancer Inst, 60, 379-384. (Pubitemid 8293580)
3. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. (1993). Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med, 119, 1198-1208. (Pubitemid 23361450)
4. Chen B, Li M, Lin M, Tumambac G, Rustum A. (2009). A comparative study of enol aldehyde formation from betamethasone, dexamethasone, beclomethasone and related compounds under acidic and alkaline conditions. Steroids, 74, 30-41.
5. Conover CD, Zhao H, Longley CB, Shum KL, Greenwald RB. (2003). Utility of poly(ethylene glycol) conjugation to create prodrugs of amphotericin B. Bioconjug Chem, 14, 661-666. (Pubitemid 36603382)
6. Danhauser-Riedl S, Hausmann E, Schick HD, Bender R, Dietzfelbinger H, Rastetter J, Hanauske AR. (1993). Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). Invest New Drugs, 11, 187-195. (Pubitemid 23277239)
7. Dekker D. (1979). Stability of corticosteroids under anaerobic conditions. I. 17-deoxyprednisolone. Pharmaceutisch Weekblad Scientific Edition. Netherlands: Springer, 1, 712-719.
8. Duggan ST, Keam SJ. (2009). Certolizumab pegol: in rheumatoid arthritis. BioDrugs, 23, 407-417.
9. Duncan R. (2009). Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt. Adv Drug Deliv Rev, 61, 1131-1148.
10. Fiehn C, Müller-Ladner U, Gay S, Krienke S, Freudenberg-Konrad S, Funk J, Ho AD, Sinn H, Wunder A. (2004a). Albumincoupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX. Rheumatology (Oxford), 43, 1097-1105. (Pubitemid 39232813)
11. Fiehn C, Neumann E, Wunder A, Krienke S, Gay S, Müller-Ladner U. (2004b). Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo. Ann Rheum Dis, 63, 884-886. (Pubitemid 38850467)
12. Fiehn C, Kratz F, Sass G, Müller-Ladner U, Neumann E. (2008). Targeted drug-delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis, 67, 1188-1191.
13. Greenwald RB, Choe YH, McGuire J, Conover CD. (2003). Effective drug-delivery by PEGylated drug conjugates. Adv Drug Deliv Rev, 55, 217-250. (Pubitemid 36135917)
14. Haag R, Kratz F. (2006). Polymer therapeutics: concepts and applications. Angew Chem Int Ed Engl, 45, 1198-1215. (Pubitemid 44097641)
15. Haynes RC. (1992). Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The Pharmacological Basis of Therapeutics. Vol. II, Singapore: Mc Graw-Hill Book Co, 1431.
16. Iwai K, Maeda H, Konno T. (1984). Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res, 44, 2115-2121. (Pubitemid 14145739)
17. Jain RK. (1990a). Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res, 50, 814s-819s.
18. Jain RK. (1990b). Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev, 9, 253-266. (Pubitemid 20380382)
19. Jain RK. (1998). Delivery of molecular and cellular medicine to solid tumors. J Control Release, 53, 49-67. (Pubitemid 28218689)
20. Krammer PH, Citronbaum R, Read SE, Forni L, Lang R. (1976). Murine thymic lymphomas as model tumors for T-cell studies. T-cell markers, immunoglobulin and Fc-receptors on AKR thymomas. Cell Immunol, 21, 97-111.
21. Kratz F, Beyer U, Schütte MT. (1999). Drug-polymer conjugates containing acid-cleavable bonds. Crit Rev Ther Drug Carrier Syst, 16, 245-288. (Pubitemid 29305204)
22. Levick JR. (1990). Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol, 17, 579-582. (Pubitemid 20201730)
23. Liu XM, Quan LD, Tian J, Alnouti Y, Fu K, Thiele GM, Wang D. (2008). Synthesis and evaluation of a well-defined HPMA copolymerdexamethasone conjugate for effective treatment of rheumatoid arthritis. Pharm Res, 25, 2910-2919.
24. Lorenz H-M. (2003). Molekulare grundlagen der behandlung rheumatischer erkrankungen. In: Ganten D, Ruckpaul K, Gay S, Kalden JR, eds. Molekularmedizinische Grundlagen von rheumatischen Erkrankungen. Heidelberg: Springer Verlag, 237.
25. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. (2000). Tumor vascular permeability and the EPR-effect in macromolecular therapeutics: a review. J Control Release, 65, 271-284. (Pubitemid 30122932)
26. Manz B, Grill HJ, Pollow K. (1982). Steroid side-chain modification and receptor affinity: binding of synthetic derivatives of corticoids to human spleen tumor and rat liver glucocorticoid receptors. J Steroid Biochem, 17, 335-342. (Pubitemid 13224778)
27. Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 46, 6387-6392. (Pubitemid 17221789)
28. Mellman I, Fuchs R, Helenius A. (1986). Acidification of the endocytic and exocytic pathways. Annu Rev Biochem, 55, 663-700. (Pubitemid 16070784)
29. Melmed GY, Targan SR, Yasothan U, Hanicq D, Kirkpatrick P. (2008). Certolizumab pegol. Nat Rev Drug Discov, 7, 641-642.
30. Midelfart A, Dybdahl A, MUller N, Sitter B, Gribbestad IS, Krane J. (1998). Dexamethasone and dexamethasone phosphate detected by 1H and 19F NMR spectroscopy in the aqueous humour. Exp Eye Res, 66, 327-337. (Pubitemid 28179254)
31. Multani AS, Li C, Ozen M, Yadav M, Yu DF, Wallace S, Pathak S. (1997). Paclitaxel and water-soluble poly (l-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. Anticancer Res, 17, 4269-4274. (Pubitemid 28081698)
32. Ohkuma S, Poole B. (1981). Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol, 90, 656-664. (Pubitemid 12254921)
33. Poole B, Ohkuma S. (1981). Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol, 90, 665-669. (Pubitemid 12254922)
34. Putnam D, Kopecek J. (1995). Polymer conjugates with anticancer activity. Advances in Polymer Science. Berlin/Heidelberg: Springer, 55.
35. Richardson SC, Wallom KL, Ferguson EL, Deacon SP, Davies MW, Powell AJ, Piper RC, Duncan R. (2008). The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug-delivery. J Control Release, 127, 1-11.
36. Rodrigues PC, Beyer U, Schumacher P, Roth T, Fiebig HH, Unger C, Messori L, Orioli P, Paper DH, Mulhaupt R, Kratz F. (1999). Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. Bioorg Med Chem, 7, 2517-2524. (Pubitemid 30122753)
37. Seymour LW, Miyamoto Y, Maeda H, Brereton M, Strohalm J, Ulbrich K, Duncan R. (1995). Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur J Cancer, 31A, 766-770.
38. Stella VJ, Charman WN, Naringrekar VH. (1985). Prodrugs. Do they have advantages in clinical practice? Drugs, 29, 455-473. (Pubitemid 15056470)
39. Stellato C. (2004). Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc, 1, 255-263.
40. Szekely JG, Lobreau AU, Einspenner M, Raaphorst GP. (1987). The use of flow cytometry to measure glucocorticoid-induced killing of lymphoid cell lines. Basic Appl Histochem, 31, 153-164. (Pubitemid 17107316)
41. van den Berg F. (2003). Synovial fluid. In: Applied Physiology (PP. 142). Vol. 1. Stuttgart: Georg Thieme Verlag.
42. Wang D, Miller SC, Liu XM, Anderson B, Wang XS, Goldring SR. (2007). Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res Ther, 9, R2.
43. Wilson VS, Bobseine K, Lambright CR, Gray LE Jr. (2002). A novel cell line, MDA-kb2, that stably expresses an androgenand glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol Sci, 66, 69-81. (Pubitemid 34202030)
44. Wunder A, Müller-Ladner U, Stelzer EH, Funk J, Neumann E, Stehle G, Pap T, Sinn H, Gay S, Fiehn C. (2003). Albumin-based drug-delivery as novel therapeutic approach for rheumatoid arthritis. J Immunol, 170, 4793-4801. (Pubitemid 36519989)
45. Zacchigna M, Cateni F, Di LG, Voinovich D, Perissutti B, Drioli S, Bonora GM. (2008). Synthesis of a new mPEG-dexamethasone conjugate and preliminary bioavailability studies in rabbits. J Drug Del Sci Tech, 18, 155-159.
46. Zunino F, Giuliani F, Savi G, Dasdia T, Gambetta R. (1982). Antitumor activity of daunorubicin linked to poly-l-aspartic acid. Int J Cancer, 30, 465-470. (Pubitemid 12003733)